Essex Bio-Technology Limited (1061.HK)
HKD 2.76
(0.37%)
HKD 2.76
(0.37%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.7 Billion HKD | 29.51% |
| 2022 | 1.31 Billion HKD | -19.54% |
| 2021 | 1.63 Billion HKD | 67.43% |
| 2020 | 978.11 Million HKD | -23.55% |
| 2019 | 1.27 Billion HKD | 8.76% |
| 2018 | 1.17 Billion HKD | 30.78% |
| 2017 | 899.58 Million HKD | 15.98% |
| 2016 | 775.66 Million HKD | 18.6% |
| 2015 | 654.01 Million HKD | 26.18% |
| 2014 | 518.29 Million HKD | 49.35% |
| 2013 | 347.04 Million HKD | 29.86% |
| 2012 | 267.25 Million HKD | 25.64% |
| 2011 | 212.71 Million HKD | 45.42% |
| 2010 | 146.28 Million HKD | 25.36% |
| 2009 | 116.68 Million HKD | -45.49% |
| 2008 | 214.07 Million HKD | 40.21% |
| 2007 | 152.67 Million HKD | 84.41% |
| 2006 | 82.78 Million HKD | 68.28% |
| 2005 | 49.19 Million HKD | 26.45% |
| 2004 | 38.9 Million HKD | 3.51% |
| 2003 | 37.58 Million HKD | 5.36% |
| 2002 | 35.67 Million HKD | 20.0% |
| 2001 | 29.72 Million HKD | 32.77% |
| 2000 | 22.39 Million HKD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 811.63 Million HKD | 0.0% |
| 2023 Q2 | 899.35 Million HKD | 0.0% |
| 2023 FY | 1.7 Billion HKD | 29.51% |
| 2023 Q4 | 807.19 Million HKD | 0.0% |
| 2022 FY | 1.31 Billion HKD | -19.54% |
| 2022 Q2 | 655.82 Million HKD | 0.0% |
| 2022 Q4 | 661.88 Million HKD | 0.0% |
| 2021 Q2 | 737.37 Million HKD | 0.0% |
| 2021 FY | 1.63 Billion HKD | 67.43% |
| 2021 Q4 | 900.28 Million HKD | 0.0% |
| 2020 Q2 | 323.83 Million HKD | 0.0% |
| 2020 Q4 | 654.27 Million HKD | 0.0% |
| 2020 FY | 978.11 Million HKD | -23.55% |
| 2019 FY | 1.27 Billion HKD | 8.76% |
| 2019 Q4 | 697.76 Million HKD | 0.0% |
| 2019 Q2 | 581.71 Million HKD | 0.0% |
| 2018 Q2 | 561.27 Million HKD | 0.0% |
| 2018 FY | 1.17 Billion HKD | 30.78% |
| 2018 Q4 | 615.17 Million HKD | 0.0% |
| 2017 FY | 899.58 Million HKD | 15.98% |
| 2017 Q4 | 461.95 Million HKD | 0.0% |
| 2017 Q2 | 437.63 Million HKD | 0.0% |
| 2016 Q2 | 363.94 Million HKD | 0.0% |
| 2016 FY | 775.66 Million HKD | 18.6% |
| 2016 Q4 | 411.71 Million HKD | 0.0% |
| 2015 Q2 | 313.41 Million HKD | 0.0% |
| 2015 Q4 | 340.59 Million HKD | 0.0% |
| 2015 FY | 654.01 Million HKD | 26.18% |
| 2014 Q4 | 286.96 Million HKD | 0.0% |
| 2014 Q2 | 231.33 Million HKD | 0.0% |
| 2014 FY | 518.29 Million HKD | 49.35% |
| 2013 FY | 347.04 Million HKD | 29.86% |
| 2013 Q4 | 181.89 Million HKD | 0.0% |
| 2013 Q2 | 165.15 Million HKD | 0.0% |
| 2012 FY | 267.25 Million HKD | 25.64% |
| 2012 Q4 | - HKD | 0.0% |
| 2012 Q2 | - HKD | 0.0% |
| 2011 Q2 | - HKD | 0.0% |
| 2011 Q4 | - HKD | 0.0% |
| 2011 FY | 212.71 Million HKD | 45.42% |
| 2010 FY | 146.28 Million HKD | 25.36% |
| 2010 Q2 | 37.57 Million HKD | 0.0% |
| 2009 Q2 | 29.4 Million HKD | 0.0% |
| 2009 FY | 116.68 Million HKD | -45.49% |
| 2008 FY | 214.07 Million HKD | 40.21% |
| 2007 FY | 152.67 Million HKD | 84.41% |
| 2006 FY | 82.78 Million HKD | 68.28% |
| 2005 FY | 49.19 Million HKD | 26.45% |
| 2004 FY | 38.9 Million HKD | 3.51% |
| 2003 FY | 37.58 Million HKD | 5.36% |
| 2002 FY | 35.67 Million HKD | 20.0% |
| 2001 FY | 29.72 Million HKD | 32.77% |
| 2000 FY | 22.39 Million HKD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 259.15 Million HKD | -558.5% |
| Grand Pharmaceutical Group Limited | 10.52 Billion HKD | 83.793% |
| Extrawell Pharmaceutical Holdings Limited | 59.09 Million HKD | -2787.672% |
| Wai Yuen Tong Medicine Holdings Limited | 783.88 Million HKD | -117.706% |
| Qianhai Health Holdings Limited | 961.29 Million HKD | -77.528% |
| Lee's Pharmaceutical Holdings Limited | 1.05 Billion HKD | -62.061% |
| Tongfang Kontafarma Holdings Limited | 809.1 Million HKD | -110.918% |
| PuraPharm Corporation Limited | 406.85 Million HKD | -319.447% |
| SSY Group Limited | 6.46 Billion HKD | 73.595% |
| JBM (Healthcare) Limited | 648.41 Million HKD | -163.189% |
| Jacobson Pharma Corporation Limited | 1.46 Billion HKD | -16.266% |
| China Resources Pharmaceutical Group Limited | 270.39 Billion HKD | 99.369% |